Trials / Completed
CompletedNCT00949546
Treatment of Hidradenitis Suppurativa Using Etanercept
Treatment of Hidradenitis Suppirativa With Etanercept Injection
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 20 (actual)
- Sponsor
- Penn State University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
Therapy with etanercept, a TNF inhibitor will reverse the inflammation, symptoms and quality of life and allow healing of HS.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | etanercept | etanercept 50 mg sc twice weekly |
Timeline
- Start date
- 2005-04-01
- Primary completion
- 2008-01-01
- Completion
- 2008-01-01
- First posted
- 2009-07-30
- Last updated
- 2017-11-24
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00949546. Inclusion in this directory is not an endorsement.